CARAWAY PHARMACEUTICALS
Pharmaceutical company · 148 brands · 128 molecules
Ranked #29 of 106 companies in Antidepressants
Company overview
CARAWAY PHARMACEUTICALS is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 148 product registrations across 128 distinct molecules. It is the 107th largest registrant in Pakistan by product count, and ranks 29th of 106 in Antidepressants. Its portfolio is concentrated in Antidepressants and Other Beta-Lactam, Cephalosporins & Penems. DRAP has issued 2 alerts involving its products.
Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.
Products by CARAWAY
1 product matched in our catalogue — each with its observed price and DRAP approved ceiling.
Top molecules by brand count
Therapeutic classes
Conditions treated
Price band (DRAP official ceilings)
Regulatory record
2 alerts in the DRAP feed we track.
Competitive set
Companies whose registered portfolio overlaps most with this one.
Portfolio whitespace
Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.
Get the full profile for CARAWAY
This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.
Request this brief See what’s included